Children's and parents' perspectives on open‐label use of placebos in the treatment of ADHD

200740 citationsJournal Article

Authors

Anthony D. Sandler · University of North Carolina at Chapel Hill

Corrine Glesne · Mission Children's Hospital

Gail Geller · Johns Hopkins Berman Institute of Bioethics

Abstract

Open-label use of placebos as part of CPDR treatment may represent an innovative, ethical way of harnessing the power of placebos in clinical therapeutics.

Topics & Keywords

Attention Deficit Hyperactivity Disorder Pain Management and Placebo Effect Pharmaceutical studies and practices

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Child Care Health and Development

Volume 34, Issue 1, pp. 111-120

DOI: 10.1111/j.1365-2214.2007.00743.x

Field-Weighted Citation Impact: 0.48